Works matching IS 11707690 AND DT 2020 AND VI 38 AND IP 10

Results: 10

Correction to: Calculating and Interpreting ICERs and Net Benefit.
Published in:
2020
By:
- Paulden, Mike
Publication type:
Correction Notice
Incorporating Pharmacometrics into Pharmacoeconomic Models: Applications from Drug Development.
Published in:
PharmacoEconomics, 2020, v. 38, n. 10, p. 1031, doi. 10.1007/s40273-020-00944-0
By:
- Srinivasan, Meenakshi;
- White, Annesha;
- Chaturvedula, Ayyappa;
- Vozmediano, Valvanera;
- Schmidt, Stephan;
- Plouffe, Leo;
- Wingate, La'Marcus T.
Publication type:
Article
Perspective and Costing in Cost-Effectiveness Analysis, 1974-2018.
Published in:
2020
By:
- Kim, David D.;
- Silver, Madison C.;
- Kunst, Natalia;
- Cohen, Joshua T.;
- Ollendorf, Daniel A.;
- Neumann, Peter J.
Publication type:
journal article
Cannabidiol for Adjuvant Treatment of Seizures Associated with Lennox-Gastaut Syndrome and Dravet Syndrome: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Published in:
2020
By:
- Wijnen, Ben;
- Armstrong, Nigel;
- Ramaekers, Bram;
- Witlox, Willem;
- Westwood, Marie;
- Fayter, Debra;
- Ryder, Steve;
- Buksnys, Titas;
- Worthy, Gill;
- Misso, Kate;
- Grimm, Sabine;
- Kleijnen, Jos;
- Joore, Manuela
Publication type:
journal article
Cost of Nine Pediatric Infectious Illnesses in Low- and Middle-Income Countries: A Systematic Review of Cost-of-Illness Studies.
Published in:
PharmacoEconomics, 2020, v. 38, n. 10, p. 1071, doi. 10.1007/s40273-020-00940-4
By:
- de Broucker, Gatien;
- Sim, So Yoon;
- Brenzel, Logan;
- Gross, Margaret;
- Patenaude, Bryan;
- Constenla, Dagna O.
Publication type:
Article
Novel Treatment Strategies for Secondary Prevention of Cardiovascular Disease: A Systematic Review of Cost-Effectiveness.
Published in:
PharmacoEconomics, 2020, v. 38, n. 10, p. 1095, doi. 10.1007/s40273-020-00936-0
By:
- Marquina, Clara;
- Zomer, Ella;
- Vargas-Torres, Sandra;
- Zoungas, Sophia;
- Ofori-Asenso, Richard;
- Liew, Danny;
- Ademi, Zanfina
Publication type:
Article
Surrogate Endpoints in Health Technology Assessment: An International Review of Methodological Guidelines.
Published in:
PharmacoEconomics, 2020, v. 38, n. 10, p. 1055, doi. 10.1007/s40273-020-00935-1
By:
- Grigore, Bogdan;
- Ciani, Oriana;
- Dams, Florian;
- Federici, Carlo;
- de Groot, Saskia;
- Möllenkamp, Meilin;
- Rabbe, Stefan;
- Shatrov, Kosta;
- Zemplenyi, Antal;
- Taylor, Rod S.
Publication type:
Article
Market Exclusivity for Drugs with Multiple Orphan Approvals (1983-2017) and Associated Budget Impact in the US.
Published in:
2020
By:
- Padula, William V.;
- Parasrampuria, Sonal;
- Socal, Mariana P.;
- Conti, Rena M.;
- Anderson, Gerard F.
Publication type:
journal article
External Validation of the Core Obesity Model to Assess the Cost-Effectiveness of Weight Management Interventions.
Published in:
PharmacoEconomics, 2020, v. 38, n. 10, p. 1123, doi. 10.1007/s40273-020-00941-3
By:
- Lopes, Sandra;
- Johansen, Pierre;
- Lamotte, Mark;
- McEwan, Phil;
- Olivieri, Anamaria-Vera;
- Foos, Volker
Publication type:
Article
Future of Data Analytics in the Era of the General Data Protection Regulation in Europe.
Published in:
2020
By:
- Kolasa, Katarzyna;
- Ken Redekop, W.;
- Berler, Alexander;
- Zah, Vladimir;
- Asche, Carl V.
Publication type:
journal article